What Expanded ASCO BRCA1/2 Mutation Testing Guidelines Mean for Your Cancer Center
What happens when many more breast cancer patients are suddenly eligible for services that are already in high demand? A much larger pool of patients...
What happens when many more breast cancer patients are suddenly eligible for services that are already in high demand? A much larger pool of patients...
When the pink's packed away, and screening isn't top of mind come November, many of the women who have flocked to their local breast centers to get...
High-risk breast programs increase rates of early cancer detection, improving patient outcomes, lowering the cost of care and engaging patients in...
Today kicks off the National Society of Genetic Counselors Annual Conference in Chicago, and we are so excited at CancerIQ to welcome the incredible...
Drs. Diane Stoller and Suzanne Hoekstra were so adamant about bringing cancer genetic testing to their community that they spearheaded a high-risk...
Now that we're transitioning from Ovarian Cancer Awareness Month to Breast Cancer Awareness Month, I’d like to shine the spotlight on the incredible...
In honor of #PrevivorDay, I’d like to celebrate the people who’ve taken action to learn their cancer risk and the providers who’ve equipped them to...
I’m incredibly proud that CancerIQ is officially a member of the CancerX Moonshot initiative, an innovative partnership led by the Digital Medicine...
How NCCN Guidelines and the Tyrer-Cuzick Lifetime Model differ and why programs are missing patients.
OSF HealthCare, one of our longstanding partners, recently enhanced their program with a hybrid HL7 and FHIR integration with CancerIQ to integrate...